Insiders · COYA

COYA insider transactions

Coya Therapeutics Inc. (COYA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for COYA

• 62d
  SEC Form 4 filed by Pavao Mark H

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 62d
  SEC Form 3 filed by new insider Pavao Mark H

  3 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 135d
  SEC Form 4 filed by Chief Financial Officer Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 135d
  SEC Form 4 filed by Chief Executive Officer Swaminathan Arun

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 135d
  SEC Form 4 filed by Chief Medical Officer Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 135d
  SEC Form 4 filed by Executive Chairman Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 155d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 295d
  Director Goldstein Dov A Md exercised 17,557 shares at a strike of $1.09, increasing direct ownership by 176% to 27,557 units (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 470d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 513d
  SEC Form 4 filed by Chief Medical Officer Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 513d
  SEC Form 4 filed by Chief Executive Officer Swaminathan Arun

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 513d
  SEC Form 4 filed by Director Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 513d
  SEC Form 4 filed by Chief Financial Officer Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Villalobos Anabella

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Goldstein Dov A Md

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Ross Wilbur L Jr

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Lee Ann

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 523d
  SEC Form 4 filed by Director Weinand Dieter

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 573d
  Chief Financial Officer Snyder David S bought $12,934 worth of shares (1,800 units at $7.19), increasing direct ownership by 26% to 8,800 units (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 574d
  Chief Executive Officer Swaminathan Arun bought $36,797 worth of shares (5,000 units at $7.36), increasing direct ownership by 100% to 10,000 units (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 575d
  Chief Medical Officer Grossman Fred bought $19,973 worth of shares (2,710 units at $7.37) (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 575d
  Chief Executive Officer Swaminathan Arun bought $36,689 worth of shares (5,000 units at $7.34) (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 659d
  SEC Form 3 filed by new insider Swaminathan Arun

  3 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Grossman Fred

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Snyder David S

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 735d
  SEC Form 4 filed by Berman Howard

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)
• 827d
  Lee Ann bought $3,620 worth of shares (1,000 units at $3.62) (SEC Form 4)

  4 - Coya Therapeutics, Inc. (0001835022) (Issuer)